Contact
searchSearch
HMP Global

Asembia Partner Spotlight

Partner Spotlight
SPONSORED

Asembia: More Than an Annual Conference
04/15/2024

Emry Lloyd

Emry Lloyd
Asembia, established in 2005, pioneered the recognition and promotion of specialty pharmacies, focusing on becoming a leader in the specialty pharmacy group purchasing organization sector. Offering scalable solutions, including prescription...
Asembia, established in 2005, pioneered the recognition and promotion of specialty pharmacies, focusing on becoming a leader in the specialty pharmacy group purchasing organization sector. Offering scalable solutions, including prescription...
Asembia, established in 2005,...
04/15/2024
First Report Managed Care

Conference Coverage
Centering Patients Within Value-Based Care
07/30/2024
Olivia Banyon; Sean McCabe
Asembia 2024 speakers Olivia Banyon and Sean McCabe discuss the concept of value-based care, patient-centered care, clinician well-being, and system workflows to improve the quality of life for patients.
Asembia 2024 speakers Olivia Banyon and Sean McCabe discuss the concept of value-based care, patient-centered care, clinician well-being, and system workflows to improve the quality of life for patients.
Asembia 2024 speakers Olivia...
07/30/2024
First Report Managed Care
Bill McElnea
Conference Coverage
Unlocking the Value-Based Care Potential of Health System Specialty Pharmacies
07/26/2024
Bill McElnea
Asembia 2024 speaker Bill McElnea discusses the role of health system specialty pharmacies in reducing total cost of care, enhancing medication adherence, and improving outcomes under value-based care arrangements.
Asembia 2024 speaker Bill McElnea discusses the role of health system specialty pharmacies in reducing total cost of care, enhancing medication adherence, and improving outcomes under value-based care arrangements.
Asembia 2024 speaker Bill...
07/26/2024
First Report Managed Care
Interview
Enhancing Patient Services: Payer and Provider Considerations
06/28/2024
Patient services emerged as a central topic at AXS24, with many stakeholders emphasizing the need for consistency and accessibility in patient support. They also highlighted the importance of addressing both financial and emotional support...
Patient services emerged as a central topic at AXS24, with many stakeholders emphasizing the need for consistency and accessibility in patient support. They also highlighted the importance of addressing both financial and emotional support...
Patient services emerged as a...
06/28/2024
First Report Managed Care
Advanced Squamous Cell Carcinoma of the Anal Canal
Videos
Evaluating Retifanlimab for Advanced Squamous Cell Carcinoma of the Anal Canal in the Frontline Setting
03/31/2026
Lingbin Meng, MD, PhD
Lingbin Meng, MD, discusses how adding retifanlimab to chemotherapy may reshape frontline treatment for advanced squamous cell carcinoma of the anal canal.
Lingbin Meng, MD, discusses how adding retifanlimab to chemotherapy may reshape frontline treatment for advanced squamous cell carcinoma of the anal canal.
Lingbin Meng, MD, discusses how...
03/31/2026
First Report Managed Care
Al B. Benson, III, MD, FACP, FASCO
Videos
First-Line Immunotherapy in Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC): Evidence Review
03/31/2026
Al B. Benson, III, MD, FACP, FASCO
Dr Benson reviews the epidemiology and unmet clinical need in advanced squamous cell carcinoma of the anal canal (SCAC) and examines the evolving role of immunotherapy in the first-line setting. He also contextualizes recent regulatory and...
Dr Benson reviews the epidemiology and unmet clinical need in advanced squamous cell carcinoma of the anal canal (SCAC) and examines the evolving role of immunotherapy in the first-line setting. He also contextualizes recent regulatory and...
Dr Benson reviews the...
03/31/2026
First Report Managed Care
Videos
Can Agentic AI Deliver? Rethinking Innovation, ROI, and Risk in Managed Care
03/30/2026
Andy De, CMO
A guest expert explains why generative AI has largely stalled in health care and argues that agentic AI—focused on automating workflows and driving action—offers a more practical path to measurable ROI, improved clinician productivity, and...
A guest expert explains why generative AI has largely stalled in health care and argues that agentic AI—focused on automating workflows and driving action—offers a more practical path to measurable ROI, improved clinician productivity, and...
A guest expert explains why...
03/30/2026
First Report Managed Care
MANAGED CARE Q&A
Why Emotional Readiness Matters in Specialty Drug Management
03/26/2026
Abby Reynolds, PharmD
In this interview, a guest expert explains why emotional readiness—not motivation or access alone—often determines whether patients can successfully initiate and persist on specialty therapies.
In this interview, a guest expert explains why emotional readiness—not motivation or access alone—often determines whether patients can successfully initiate and persist on specialty therapies.
In this interview, a guest...
03/26/2026
First Report Managed Care
PIPELINE PROJECTIONS
Emerging Therapies Reshaping Atopic Dermatitis Care
03/26/2026
Roy Moore
Roy Moore outlines how a rapidly expanding atopic dermatitis pipeline is intensifying competition, reshaping payer strategies, and raising the bar for new therapies.
Roy Moore outlines how a rapidly expanding atopic dermatitis pipeline is intensifying competition, reshaping payer strategies, and raising the bar for new therapies.
Roy Moore outlines how a rapidly...
03/26/2026
First Report Managed Care
MANAGED CARE Q&A
Beyond the Pharmacy Benefit: Managing Specialty Drug Costs in an Era of Rapid Growth
03/26/2026
Allison Oakes, PhD
A guest expert explains why specialty drugs dominating US spending is forcing payers to rethink benefit design, oncology strategy, and biosimilar adoption to control costs and improve value.
A guest expert explains why specialty drugs dominating US spending is forcing payers to rethink benefit design, oncology strategy, and biosimilar adoption to control costs and improve value.
A guest expert explains why...
03/26/2026
First Report Managed Care
Conference Coverage
IRA Implementation and the Financial Rewiring of Medicare Part D
03/11/2026
Hannah Musick
As the Inflation Reduction Act (IRA) fundamentally restructures Medicare Part D financing, payers and manufacturers are recalibrating bid strategies, contracting models, and formulary decision-making ahead of 2026 implementation milestones.
As the Inflation Reduction Act (IRA) fundamentally restructures Medicare Part D financing, payers and manufacturers are recalibrating bid strategies, contracting models, and formulary decision-making ahead of 2026 implementation milestones.
As the Inflation Reduction Act...
03/11/2026
First Report Managed Care
Conference Coverage
Specialty Drug Strategy in a High-Cost, High-Scrutiny Environment
03/10/2026
Hannah Musick
As oncology, rare disease, and gene therapy pipelines expand, managed care leaders are recalibrating specialty drug strategies to manage escalating costs while preserving patient access and clinical innovation.
As oncology, rare disease, and gene therapy pipelines expand, managed care leaders are recalibrating specialty drug strategies to manage escalating costs while preserving patient access and clinical innovation.
As oncology, rare disease, and...
03/10/2026
First Report Managed Care
Conference Coverage
Navigating the New Affordability Landscape: PDABs, Copay Programs, and Alternative Funding Models
03/09/2026
Hannah Musick
As states expand Prescription Drug Affordability Review Board (PDAB) authority and copay accumulator bans gain traction, managed care stakeholders are reassessing benefit design, reimbursement strategy, and contracting models in response to a...
As states expand Prescription Drug Affordability Review Board (PDAB) authority and copay accumulator bans gain traction, managed care stakeholders are reassessing benefit design, reimbursement strategy, and contracting models in response to a...
As states expand Prescription...
03/09/2026
First Report Managed Care
Conference Coverage
AI and Real-World Evidence in Pharmacy Benefit Decision-Making
03/09/2026
Hannah Musick
Growing reliance on advanced analytics and real-world evidence is redefining reimbursement evaluation, prior authorization efficiency, and value-based contracting—signaling a shift toward more data-driven pharmacy benefit management.
Growing reliance on advanced analytics and real-world evidence is redefining reimbursement evaluation, prior authorization efficiency, and value-based contracting—signaling a shift toward more data-driven pharmacy benefit management.
Growing reliance on advanced...
03/09/2026
First Report Managed Care

Asembia is an industry leader in the specialty pharmacy sector. It aims to connect and strengthen the pharmaceutical industry and transform its ideas into significant innovations, all dedicated to optimizing and improving patients' experiences worldwide. Visit asembia.com for more information.

 

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use